Two drugmakers in the country have requested permission to end their late-stage trials on Merck & Co's experimental antiviral drug molnupiravir in moderate COVID-19 patients.
from NDTV News - Topstories https://ift.tt/3iFD1JW
MASIGNASUKAv102
6510051498749449419
comment 0 Comments
more_vert